Polypid Ltd
Polypid Ltd (PYPD) Covered Calls
As of September 25, 2026, PYPD has 2 covered call opportunities in the coming three months. Return ranges from 46.6 to 55.2% until expiration. Annualized return ranges from 71.4 to 137.0%. The nearest expiration is February 19, 2027. Maximum potential profit is $288.
Read more
Running PYPD covered calls helps you generate consistent income from Polypid Ltd's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Polypid Ltd involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PYPD covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PYPD stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PYPD covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Polypid Ltd covered call is worth writing.
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Income-focused investors, long-term PYPD holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PYPD covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Polypid Ltd covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)106
- 52 weeks high-8.90%
- 52 weeks low70.59%
- Analyst recommendationStrong Buy
1.00 - Target price$11.75
125.10% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.48
- EPS growth next 5 years41.71%
As of September 25, 2026
| 2027-02-19 | 147 | 7.50 | 43.68 | 0.60 | 1.85 | 288.00 | 55.17 | 136.99 | -11.49 | +0.52 | 308 | 1.25 |
| 2027-05-21 | 238 | 7.50 | 43.68 | 0.15 | 2.85 | 243.00 | 46.55 | 71.39 | -2.87 | +0.57 | 0 | 2.70 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best PYPD covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→